Initially described as “plasma cell pneumonia”, pulmonary infection with the microorganism Pneumocystis jiroveci (formerly known as Pnemocystis carinii) was first identified in malnourished infants, ... Pneumocystis pneumonia is a potentially life-endangering disease caused by the fungal pathogen Pneumocystis jiroveci. It is predominantly observed in immunocompromised individuals.
This microorganism ... Please provide your email address to receive an email when new articles are posted on . Concomitant steroid-pulse treatment and baseline lymphopenia were among risk factors for pneumocystis pneumonia ... JSTOR Daily: β-Glucans Are Masked but Contribute to Pulmonary Inflammation During Pneumocystis Pneumonia In the period October 1980-May 1981, 5 young men, all active homosexuals, were treated for biopsy-confirmed Pneumocystis carinii pneumonia at 3 different hospitals in Los Angeles, California.
pneumocystis pneumonia, Two of ... FierceBiotech: Press Release: Par Pharmaceutical Gets Rights for Immtech Pharmaceuticals's Pneumocystis Pneumonia Drug Par Pharmaceutical Gets Rights for Immtech Pharmaceuticals's Pneumocystis Pneumonia Drug WOODCLIFF LAKE, N.J., June 12 -- Par Pharmaceutical Companies, Inc. today announced it has entered into an ... Press Release: Par Pharmaceutical Gets Rights for Immtech Pharmaceuticals's Pneumocystis Pneumonia Drug
